Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?
Arcturus Therapeutics Ownership Summary
Arcturus Therapeutics is owned by 98.09% institutional investors, 7.89% insiders. Federated hermes is the largest institutional shareholder, holding 17.35% of ARCT shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 8.98% of its assets in Arcturus Therapeutics shares.
ARCT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcturus Therapeutics | 98.09% | 7.89% | -5.98% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Federated hermes | 4.69M | 17.35% | $79.66M |
| Blackrock funding, inc. /de | 2.99M | 11.05% | $50.73M |
| Sumitomo mitsui trust | 2.07M | 7.63% | $35.04B |
| Nikko asset management americas | 2.07M | 7.63% | $34.94M |
| Ark investment management | 1.93M | 7.15% | $32.82M |
| Vanguard group | 1.68M | 6.22% | $28.59M |
| State street | 1.33M | 4.90% | $22.50M |
| Schonfeld strategic advisors | 849.08K | 3.14% | $14.41M |
| Woodline partners lp | 806.91K | 2.98% | $13.69M |
| Dimensional fund advisors lp | 707.40K | 2.61% | $12.00M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 200.00K | 0.46% | $3.39M |
| Nikko asset management americas | 2.07M | 0.38% | $34.94M |
| Empire life investments | 279.46K | 0.30% | $4.74M |
| Ark investment management | 1.93M | 0.27% | $32.82M |
| Federated hermes | 4.69M | 0.17% | $79.66M |
| J. goldman & co lp | 296.05K | 0.13% | $5.02M |
| Belmont capital | 40.00K | 0.11% | $678.80K |
| Woodline partners lp | 806.91K | 0.09% | $13.69M |
| Schonfeld strategic advisors | 849.08K | 0.08% | $14.41M |
| Hennion & walsh asset management | 82.06K | 0.06% | $1.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Balyasny asset management | 548.76K | 0.01% | 548.76K |
| Schonfeld strategic advisors | 849.08K | 0.08% | 479.48K |
| J. goldman & co lp | 296.05K | 0.13% | 296.05K |
| Ikarian capital | 200.00K | 0.46% | 200.00K |
| Empire life investments | 279.46K | 0.30% | 128.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -459.94K |
| Nikko asset management americas | 2.07M | 0.38% | -250.24K |
| Millennium management | - | - | -236.07K |
| Sumitomo mitsui trust | 2.07M | 0.02% | -210.66K |
| Ark investment management | 1.93M | 0.27% | -167.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| J. goldman & co lp | 296.05K | 0.13% | 296.05K | $5.02M |
| Ikarian capital | 200.00K | 0.46% | 200.00K | $3.39M |
| Boothbay fund management | 58.94K | 0.02% | 58.94K | $1.00M |
| Mai capital management | 381.00 | - | 381.00 | $6.47K |
| Skopos labs | 288.00 | 0.00% | 288.00 | $4.89K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -2.00 |
| Frazier financial advisors | -4.00 |
| Gps wealth strategies group | -10.00 |
| Geowealth management | -19.00 |
| Farther finance advisors | -47.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 148 | -5.73% | 26,589,017 | -0.21% | 98 | 1.01% | 67 | -4.29% | 49 | 4.26% |
| Dec 31, 2024 | 155 | -9.36% | 26,627,173 | 1.41% | 98 | 1.05% | 69 | -14.81% | 47 | -6.00% |
| Sep 30, 2024 | 170 | -4.49% | 26,254,877 | -0.08% | 97 | 1.02% | 81 | 5.19% | 49 | -27.94% |
| Jun 30, 2024 | 178 | -5.82% | 26,276,502 | -3.48% | 97 | 0.95% | 77 | -15.38% | 68 | 11.48% |
| Mar 31, 2024 | 189 | 9.25% | 27,224,704 | 7.13% | 101 | 1.11% | 91 | - | 61 | 15.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Federated Hermes Kaufmann Growth | 2.44M | 8.98% | - |
| Federated Hermes Kaufmann R | 2.44M | 8.98% | - |
| Federated Hermes Kaufmann Small Cap Grow | 2.20M | 8.10% | - |
| Federated Hermes Kaufmann Small Cap A | 2.20M | 8.10% | - |
| ARK Genomic Revolution | 1.98M | 7.29% | 68.22K |
| ARK Genomic Revolution ETF | 1.66M | 6.12% | -9.96K |
| Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.61M | 5.93% | -56.86K |
| Vanguard Total Stock Mkt Idx Inv | 724.72K | 2.67% | - |
| Vanguard US Total Market Shares ETF | 723.64K | 2.67% | - |
| iShares Russell 2000 ETF | 619.61K | 2.28% | -10.01K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $249.12K |
| Jun 12, 2024 | SASSINE ANDY | Chief Financial Officer | Sell | $1.60M |
| Jun 05, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $5.13K |
| Jun 03, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $1.04M |
| Mar 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | $610.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2024 Q4 | - | 1 |
| 2024 Q2 | - | 3 |
| 2024 Q1 | - | 2 |
| 2023 Q4 | - | 2 |
ARCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools